首页   按字顺浏览 期刊浏览 卷期浏览 Peripheral Arterial and Aortic DiseasesLong-Term Outcome for 120 Japanese Patients With...
Peripheral Arterial and Aortic DiseasesLong-Term Outcome for 120 Japanese Patients With Takayasu's DiseaseClinical and Statistical Analyses of Related Prognostic Factors

 

作者: Kaichiro Ishikawa,   Shunzo. Maetani,  

 

期刊: Circulation  (OVID Available online 1994)
卷期: Volume 90, issue 4  

页码: 1855-1860

 

ISSN:0009-7322

 

年代: 1994

 

出版商: OVID

 

数据来源: OVID

 

摘要:

Background Patients with Takayasu's disease, a chronic inflammatory arteriopathy of unknown cause, have variable clinical courses, and predictors of the long-term outcome are not well understood. We studied prognostic factors of this disease, based on follow-up results, and a new prognostic classification was proposed.35 years and <=35 years, and 79.9% versus 96.5% for patients diagnosed in 1957 through 1975 and in 1976 through 1990, respectively. The delay in diagnosis and the erythrocyte sedimentation rate (ESR) were of marginal significance. The multivariate Cox analysis showed that only two of the above variables were statistically independent predictors, ie, the major complication and the progressive course. In addition to these two factors, ESR was the third predictor, if the Cox stepwise elimination procedure was performed. These three predictors used in various combinations made a total of 1822 classifications theoretically feasible. Of these, a three-stage classification was selected as the best one, based on the Akaike information criterion. The presence of both major complication and progressive course (stage 3) was the worst prognostic indicator (43% survival at 15 years). In contrast, no patient died who had neither of these manifestations or who had a progressive course but an elevated ESR as well (stage 1).Conclusions The long-term outcome for patients with Takayasu's disease seems best predicted by two major prognostic factors, ie, complications and the pattern of the past clinical course, as well as by ESR. Aggressive medical and surgical treatment may be considered for patients with a major complication and a progressive course (stage 3). (Circulation. 1994;90:1855-1860.)

 



返 回